Panipenem(CAS: 87726-17-8)

Panipenem (CAS: 87726-17-8) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA guidelines for pharmaceutical and environmental safety. Manufacturers must ensure compliance with these standards for labeling, packaging, and disposal.

Alternatives to Panipenem (CAS: 87726-17-8) in synthesis include other beta-lactam antibiotics such as meropenem and imipenem. These alternatives are used when Panipenem is not viable due to toxicity, stability, or efficacy concerns. Common substituting reagents include various carboxylic acids and carbonyl compounds.

The market for Panipenem (CAS: 87726-17-8) is stable, with research focusing on its therapeutic applications in treating resistant bacterial infections. Recent trends include exploring its use in combination therapy and studying its pharmacokinetic properties. Price trends are influenced by production costs and demand in the pharmaceutical industry.

Waste containing Panipenem (CAS: 87726-17-8) should be collected in suitable containers, labeled as hazardous waste, and disposed of through professional waste disposal services. Incineration is a common method, but it must comply with local environmental regulations. Environmental protection measures include proper containment to prevent spillage and ensure safe handling and disposal.